Last updated: January 22, 2025
Sponsor: Minneapolis Heart Institute Foundation
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Open Heart Surgery
Treatment
Percutaneous coronary intervention of the native coronary artery with Synergy
Clinical Study ID
NCT05187351
NASA
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18 years or older
Presentation with a 50-100% de novo SVG lesion that is considered to cause clinicalsymptoms and is treated with percutaneous coronary intervention of the correspondingnative coronary artery using a SYNERGY stent.
Has provided informed consent and agrees to participate
Exclusion
Exclusion Criteria:
- Known comorbidities/ conditions that, in the opinion of the investigator, limit lifeexpectancy to less than 1 year
Study Design
Total Participants: 99
Treatment Group(s): 1
Primary Treatment: Percutaneous coronary intervention of the native coronary artery with Synergy
Phase:
Study Start date:
November 21, 2021
Estimated Completion Date:
January 31, 2030
Study Description
Connect with a study center
Henry Ford Health System
Detroit, Michigan 48202
United StatesSite Not Available
Minneapolis Heart Institute Foundation
MInneapolis, Minnesota 55407
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.